Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$105.93 USD
-7.27 (-6.42%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $106.01 +0.08 (0.08%) 6:32 PM ET
4-Sell of 5 4
B Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
JAZZ 105.93 -7.27(-6.42%)
Will JAZZ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JAZZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JAZZ
JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut
Jazz (JAZZ) Reports Q2 Earnings: What Key Metrics Have to Say
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss, Misses Revenue Estimates
AXSM Q2 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y
Sarepta Therapeutics (SRPT) to Report Q2 Results: Wall Street Expects Earnings Growth
Other News for JAZZ
JAZZ: Morgan Stanley Lowers Price Target, Maintains Overweight Rating | JAZZ Stock News
Jazz Pharmaceuticals price target lowered by $30 at Truist, here's why
Jazz Pharmaceuticals (JAZZ) Expects Key FDA Decision Amid Leadership Transition
Jazz Pharmaceuticals plc 2025 Q2 - Results - Earnings Call Presentation
Jazz Pharmaceuticals projects late Q4 zanidatamab Phase III data, signals leadership transition and updates 2025 guidance